Adjunctive treatment with Aripiprazole for Risperidone –induced hyperprolactinemia
Not Applicable
- Conditions
- hyperprolactinemia induced by risperidone.Hyperprolactinaemia
- Registration Number
- IRCT201307182181N6
- Lead Sponsor
- tabriz university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
inclusion criterias :
1.hyperprolactinemia
2. women in reproductive age
3.candidate for risperidone continuation
exclusion criterias:
1.previous amenorrhea
2.breastfeeding
3.pregnancy
4.renal failure
5. hypothyroidism
6. pituitary tumors
7. consumption of methyldopa, levodopa,cimethidine, strogen, opium derivatives
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum prolactin level. Timepoint: weekly for first 2 weeks then monthly for 3 months. Method of measurement: mg/dl.
- Secondary Outcome Measures
Name Time Method Drug side effect. Timepoint: the end of study. Method of measurement: patient interview.